Health Worker Training Helps More Sick Newborns Survive in Uganda

By Irene Mirembe, Knowledge management manager, IntraHealth International A baby is measured for size at the Busowobi Health Center in Iganga District, Uganda. Photo by Tommy Trenchard for IntraHealth International.November 23, 2021When 25-year-old Aida Adongo started bleeding during her seventh month of pregnancy, she knew she had to seek care quickly. By the time she reached the Lwala Hospital, the nearest health facility in her community, she had already delivered one twin. The other was born safely at the hospital, thanks to the swift response of the medical team when she arrived.In Uganda, preterm births—babies born before 37 weeks—like Aida’s are likely to occur for women who do not attend antenatal visits. This often means women living in rural areas, far from health facilities, are at a higher risk of having their babies early. Approximately226,000 babies are born too soon every year in Uganda and of these, 12,500 children under five die due to preterm complications.The Ministry of Health in Uganda is committed to improving the survival and health of newborns through high-quality maternal and newborn care, especially for babies who have a low birth weight or are sick.Lwala Hospital in the Kalaki District of eastern Uganda is one of the health facilities IntraHealth International’s USAID-fundedRegional Health Integration to Enhance Services in Eastern Uganda (RHITES-E) project supports.Through essential newborn care mentorships, RHITES-E hel...
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Tags: Family Planning & Reproductive Health Maternal, Newborn, Child Health Education Performance Health workforce development Source Type: news

Related Links:

Conclusion: A subamniotic hematoma appears to be the first manifestation of FNAIT.
Source: Fetal Diagnosis and Therapy - Category: Perinatology & Neonatology Source Type: research
Conditions:   Early Pregnancy Bleeding;   Recurrent Pregnancy Loss Intervention:   Drug: Progestagen Sponsor:   Center for Epidemiology and Health Research, Germany Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study aims to collect and analyze data in the published literature regarding the hysteroscopic management of CSPs focusing on efficacy and complications. Using a protocol registered with Prospero (#CRD42021242314), the electronic databases PubMed/Medline, Scopus, Clinical-Trials.gov and the Cochrane Library were comprehensively searched, from their inception to June 2020. Medical Subject Headings terms such as caesarean ectopic, hysteroscopy and endoscopy were used for the identification of the relevant records. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to...
Source: Reproductive Biology - Category: Reproduction Medicine Authors: Source Type: research
Spotting and light vaginal bleeding are common and usually harmless symptoms in early pregnancy. Still, vaginal bleeding may be the first sign of an abortion and often causes distress to pregnant women and lea...
Source: BMC Health Services Research - Category: General Medicine Authors: Tags: Research Source Type: research
Conclusions for PracticeImmigrant women had lower levels of knowledge about how to manage warning signs of pregnancy complications compared to women of Danish origin. Improved needs-based health education in pregnancy complications and body symptoms during antenatal care is needed to address delays in the management of complications and could potentially improve the health of women and children.
Source: Maternal and Child Health Journal - Category: Health Management Source Type: research
Alyson Isaksson Capp, PhD The dreaded pink line bleeding across the test strip next to the navy  “Like a pregnancy test—two lines means positive” said the woman in royal blue scrubs,     unphased that we all had tested positive. In awe that after almost two years the thing I had most avoided had happened, I left my body. As I looked down at myself seeing Her, my body defending HerSelf, Her tiny T cells recognizing the protein spikes,  remembering them by heart, dismantling them— Later watching as She shouldered the headaches,...
Source: blog.bioethics.net - Category: Medical Ethics Authors: Tags: COVID-19 pandemic Featured Posts Uncategorized Source Type: blogs
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson &Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson &Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Conclusion:: In conclusion, we found that in real-life conditions, the rate of bleeding events occurring during anticoagulation after a VTE episode is not higher in women than in men. Only after inclusion of vaginal bleeds, the rate of bleeding was higher in women. More bleeds (including vaginal bleeding) occurred in women treated with VKA than DOACs.PMID:34987749 | PMC:PMC8689616 | DOI:10.1177/20420986211062965
Source: Adv Data - Category: Epidemiology Authors: Source Type: research
AbstractPurpose of ReviewIn this review, we discuss the efficacy, safety, and benefits of four new contraceptive products available in the USA, specifically Annovera, Phexxi, Slynd, and Twirla.Recent FindingsAnnovera is a vaginal ring releasing ethinyl estradiol and segesterone acetate that can be used for up to one year (13 cycles), offering patients an effective, user-controlled option that may improve contraceptive access for those in low-resource settings or those with barriers to retrieving monthly prescriptions; however, given limited efficacy and safety data in people with body mass index (BMI)  >  ...
Source: Current Obstetrics and Gynecology Reports - Category: OBGYN Source Type: research
CONCLUSION: In this long-term follow-up of RRT the recurrence rate is comparable to larger individual studies of minimally invasive or vaginal radical trachelectomy with similar risk profile and follow up. The high pregnancy rate and low rate of premature delivery before 32 weeks GA may promote the use of robot-assisted approach.PMID:34980514 | DOI:10.1016/j.ygyno.2021.12.029
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research
More News: Babies | Bleeding | Child Development | Children | Education | Hospitals | International Medicine & Public Health | Men | Midwifery | OBGYN | Perinatology & Neonatology | Pregnancy | Rural Health | Skin | Training | Uganda Health | Universities & Medical Training | Women